Article
DNA methylation profiling reveals a novel subtype harboring IDH mutation in H3-altered gliomas.
Neuro-oncology - 1 Jun 2026
Fu Minjie, Feng Yuan, Sun Pin, You Muyuan, Zhang Licheng, Yang Hui, Zhang Yi, Ye Dan, Wang Jiguang, Xiong Yue, Verhaak Roel, Mao Ying, Hua Wei
Abstract excerpt
BACKGROUND: H3-altered gliomas, now recognized by WHO CNS5 as grade 4 neoplasms driven by histone H3 mutations (notably H3K27M and H3G34R/V), exhibit marked molecular heterogeneity, dismal survival, and resistance to standard therapies. Despite their classification as WHO grade 4 neoplasms, current stratification fails to capture their clinical and epigenetic diversity. METHODS: We performed genome-wide DNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
